Characterization of the metastatic melanoma population in Chile that received ipilimumab for the treatment of unresectable or metastatic melanoma

10/03/2014
14/11/2019
EU PAS number:
EUPAS6036
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

Retrospective medical records
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No